Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma. - Wikidata - awgldk - TriplyDB

Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma.

Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q44567716

about

Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results Management of borderline resectable pancreatic cancer Advances in chemotherapy for pancreatic cancer Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies.Neoadjuvant therapy in pancreatic cancer: an emerging strategy Neoadjuvant strategies for pancreatic cancer Borderline resectable pancreatic cancer: definitions and management.Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery.Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer.Capecitabine and Gemcitabine (CapGem, CG, GemCap) for Advanced Pancreatic and Biliary Tract Cancer.Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.Novel directions in neoadjuvant therapy for pancreas adenocarcinoma.Evolving treatment landscape for early and advanced pancreatic cancer.The role of neoadjuvant therapy in pancreatic cancer: a review.Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen.Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis.Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?The Role of Consolidation Chemo-Radiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability.Neoadjuvant therapy for pancreatic cancer: an ongoing debate.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer.Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer.Contemporary Management of Localized Resectable Pancreatic Cancer.Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.Medical oncology and pancreatic cancer: what the radiologist needs to know.Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection.Treatment of borderline resectable pancreatic cancer.Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.

P2860

Q26774897-97425202-4630-4DB3-820B-65E0AE4842BB Q26781445-918B864D-C827-43B4-858F-0E994925F9A1 Q28085711-953B007D-95ED-455B-A818-6B997FEF28D4 Q30414737-F2A6A4CE-707B-47B5-A638-EBBC8E761155 Q33750803-989249A0-D26C-4C1D-B314-EC848E39B781 Q33751263-1915B1B1-D670-478D-8323-4CEEBE64C005 Q33775311-5736C8E4-771D-4069-A2FA-5EC43D326CA4 Q33914671-C2715024-4275-4E25-8BB3-EE58DAA87560 Q33948343-D618AABE-2B8C-425D-B386-BA4D3DEAC096 Q34067852-26825394-D513-4494-964A-AF6A120E33AA Q34892858-A48B3F3E-565B-4C49-9C7D-6EB95BE0E0D2 Q36023889-4FEC8921-1A0E-4687-82C0-F2C707085C1F Q36531542-D31853C1-3924-45FF-A1C5-02BF5E019765 Q37277436-D19A3EC1-7773-466B-825E-9DF01B35E60C Q37614142-C2DD0B15-F433-46D1-955D-BE961EE8DA4D Q37714700-D886B8DD-F68C-40AE-818F-820006B0513E Q38084124-EC2B46C8-17C3-4293-948B-319D5F40A5C1 Q38180310-55924617-5429-4F7E-9961-D4B6F67B2884 Q38204280-467D4748-6786-4CB9-93E6-D6523DDDB4A1 Q38357201-58F45547-B795-4AD4-B8EB-8DC1B6958A2F Q38624806-72DDD7D3-EA68-46E6-A217-5BADE382CA07 Q38734981-A8C0F420-019A-4A5A-9E0A-F74E28180BD4 Q38753432-5751598B-92E4-4A37-935A-E2D78D4F05C1 Q38845950-C8D60996-E4F1-4B07-A89D-FAC13D684967 Q38905077-037FC9A8-8222-4F94-8544-FCADA3E49D3A Q39364761-AD3EFE7F-92D5-4A6A-BF01-4FDEE4EB987A Q39390859-AC4F7BCA-3E1D-4F65-BF3F-A1BF7F3BD27E Q40217786-AF446964-AF49-4EA2-B2B0-C058378D498F Q41573034-9940E159-2F8C-4710-A000-E4BA246AFA14 Q41642682-118DD927-84C7-4A75-97B5-D10DFBDDF564 Q41826893-A68D2525-DE03-4733-AA93-132E658F11FB Q42374126-3DAC51C9-B165-4CDC-9E08-FA6F0E1B829F Q46689245-D8BE4E07-593B-49FB-9D86-691B62AB9B84 Q47103986-B0B7C77C-32C1-4BA2-AE16-F510DCD932B5 Q47716584-CE8C8F6C-BA6F-44C6-9F39-F5BAE0520D45 Q48641659-5431FBEB-373C-4F5D-BBE8-A3A0FB27892C Q49504793-9B9845F7-8855-4ECF-8B2A-1D8EFDFC23DE Q50049542-E16AE7E8-F3A0-4F36-8EAF-694CA33A268B Q51196995-2EE68F23-7D49-479F-892A-40A422A115A4 Q51747980-AC857091-4C0F-4AD9-8913-034DEF95A099

P2860

Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q44567716

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@en

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@nl

type

label

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@en

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@nl

prefLabel

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@en

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@nl

P1433

Q44567716-0B902E8F-5A2B-44AB-882C-440B7E095DBD

P1476

Q44567716-01C728F5-2F4F-4487-80D3-F7D2EAF5CC98

P2093

Q44567716-0AAAF92B-A054-422D-B9DD-44102956D780

Q44567716-2AEC7DCF-7C2A-4890-BE7D-0F03ABDD8673

Q44567716-386C12E1-03F2-44F3-A903-6974D3C19EDF

Q44567716-4A5C7CDB-5997-42DD-9EF6-D5866543F55C

Q44567716-56A9CB2B-917D-4ECC-AEFB-3C7FADA76512

Q44567716-63818277-7D4B-4977-AA18-960EE4E7213D

Q44567716-80945D5B-7EEA-44A4-BB2B-EBAE1D0A0EE7

Q44567716-933F2D70-EA53-4519-9C0A-DB5DDD90DC22

Q44567716-AEC19AF6-5607-4741-AE72-D1EA22B2BC2D

Q44567716-B8530542-09AE-471B-BEA3-529C92303575

P304

Q44567716-0E33DC49-A99C-4C65-92B0-6AAE61B42734

P31

Q44567716-7F032D71-14E7-4A45-9299-B4DBCC031727

P356

Q44567716-1E79873B-00E8-40F7-8B0B-1A99730DB5EA

P407

Q44567716-139B3872-6B99-4CDE-B121-E14BF9E3E24D

P433

Q44567716-93572546-5A6F-45BF-8D64-BE364EFDC598

P478

Q44567716-5C9A7D65-A742-4323-9872-6C0FE3E4C42C

P577

Q44567716-01307072-AB44-4912-A082-2273779042CB

P698

Q44567716-557A3799-3516-4D47-8A34-1BC7729672EB

P921

Q44567716-238DE15F-9A9E-4B15-B7CC-44199AF945B3

Q44567716-5C93EE9C-73BF-4067-8E96-2FBEE1F36CB4

P356

J.SURG.2012.03.010

P1433

P1476

Prospective efficacy and safet ...... ced pancreatic adenocarcinoma.

@en

P2093

Do Hyun Park

http://www.w3.org/2001/XMLSchema#string

Dong Wan Seo

http://www.w3.org/2001/XMLSchema#string

Duck Jong Han

http://www.w3.org/2001/XMLSchema#string

Jae-Lyun Lee

http://www.w3.org/2001/XMLSchema#string

Ji-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Hong Park

http://www.w3.org/2001/XMLSchema#string

Jong Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Myung-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Sang Hyun Shin

http://www.w3.org/2001/XMLSchema#string

Sang Soo Lee

http://www.w3.org/2001/XMLSchema#string

P304

851-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SURG.2012.03.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22682078

http://www.w3.org/2001/XMLSchema#string

P921